Health promotion program for Ultra-Orthodox Jewish women during COVID-19
Partners For Life: Off-line Health Promotion Program for Ultra-orthodox Jewish Women During the COVID-19 Pandemic
This study is testing a health program designed to help Ultra-Orthodox Jewish women in Israel eat better and be more active during COVID-19.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | Female |
| Sponsor | Hadassah Medical Organization Academic / other |
| Locations | 1 site (Jerusalem) |
| Trial ID | NCT05135598 on ClinicalTrials.gov |
What this trial studies
This intervention aims to improve healthy eating and physical activity among Ultra-Orthodox Jewish women in Israel, who face unique health challenges exacerbated by the COVID-19 pandemic. The program is based on the CDC's Diabetes Prevention Program and employs low-tech media, partner learning, and group support to facilitate behavior change. Participants work in pairs, receiving a pedometer and workbook to track their progress, and engage in weekly group meetings to share experiences and problem-solve. The study evaluates the effectiveness of this culturally-tailored approach in promoting healthier lifestyles.
Who should consider this trial
Good fit: Ideal candidates are Ultra-Orthodox Jewish women aged 18-85 who are willing to commit to the lifestyle intervention.
Not a fit: Patients who are pregnant or have severe mental health conditions or certain chronic diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could lead to improved health behaviors and outcomes for Ultra-Orthodox Jewish women.
How similar studies have performed: While similar culturally-tailored interventions have shown promise, this specific approach during the COVID-19 pandemic is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Females aged 18-85, willingness to commit to participation in the lifestyle intervention and follow-up. - Exclusion Criteria: Pregnancy, history of schizophrenia, severe depression, untreated bipolar disorder, end-stage renal disease, type 1 diabetes, unstable angina, congestive heart failure, inability to participate in the group without assistance, dementia, inability to communicate in Hebrew.
Where this trial is running
Jerusalem
- Hadassah University Medical Center — Jerusalem, Israel (Recruiting)
Study contacts
- Principal investigator: Donna Zwas, MD — Hadassah
- Study coordinator: Elisheva Leiter, PhD
- Email: elisheval@hadassah.org.il
- Phone: 02-6779340
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.